GeneDx Holdings Corp (NASDAQ: WGS) kicked off on Monday, down -5.62% from the previous trading day, before settling in for the closing price of $77.20. Over the past 52 weeks, WGS has traded in a range of $1.45-$89.11.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Annual sales at Healthcare sector company grew by 5.08% over the past five years. While this was happening, its average annual earnings per share was recorded 93.74%. With a float of $21.99 million, this company’s outstanding shares have now reached $27.43 million.
Let’s look at the performance matrix of the company that is accounted for 1000 employees. In terms of profitability, gross margin is 54.23%, operating margin of -20.43%, and the pretax margin is -31.52%.
GeneDx Holdings Corp (WGS) Insider Updates
Our next focus will be how large-scale investors are participating in this stock of the Health Information Services Industry. The insider ownership of GeneDx Holdings Corp is 19.96%, while institutional ownership is 67.00%. The most recent insider transaction that took place on Dec 09 ’24, was worth 86,836. Before that another transaction happened on Dec 09 ’24, when Company’s Director proposed sale 3,661 for $76.37, making the entire transaction worth $279,598.
GeneDx Holdings Corp (WGS) Performance Highlights and Predictions
According to the Wall Street analysts, stocks earnings will be around 93.74% per share during the next fiscal year.
GeneDx Holdings Corp (NASDAQ: WGS) Trading Performance Indicators
Take a look at GeneDx Holdings Corp’s (WGS) current performance indicators. Last quarter, stock had a quick ratio of 2.27. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 7.33.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -3.17, a number that is poised to hit 0.11 in the next quarter and is forecasted to reach 0.49 in one year’s time.
Technical Analysis of GeneDx Holdings Corp (WGS)
GeneDx Holdings Corp (NASDAQ: WGS) saw its 5-day average volume 0.65 million, a positive change from its year-to-date volume of 0.46 million. As of the previous 9 days, the stock’s Stochastic %D was 38.79%. Additionally, its Average True Range was 6.68.
During the past 100 days, GeneDx Holdings Corp’s (WGS) raw stochastic average was set at 74.53%, which indicates a significant increase from 31.94% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 58.50% in the past 14 days, which was lower than the 93.69% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $67.32, while its 200-day Moving Average is $34.48. Nevertheless, the first resistance level for the watch stands at $78.85 in the near term. At $84.84, the stock is likely to face the second major resistance level. The third major resistance level sits at $89.13. If the price goes on to break the first support level at $68.57, it is likely to go to the next support level at $64.28. Assuming the price breaks the second support level, the third support level stands at $58.29.
GeneDx Holdings Corp (NASDAQ: WGS) Key Stats
The company with the Market Capitalisation of 1.96 billion has total of 27,471K Shares Outstanding. Its annual sales at the moment are 202,570 K in contrast with the sum of -175,770 K annual income. Company’s last quarter sales were recorded 76,870 K and last quarter income was -8,310 K.
